Steckler Rafi, Magzal Faiga, Kokot Marta, Walkowiak Jaroslaw, Tamir Snait
Department of Pediatric Gastroenterology and Metabolic Diseases, Institute of Pediatrics, Poznan University of Medical Sciences, Poland.
Tel Hai Academic College, Israel.
Brain Behav Immun Health. 2024 Jul 27;40:100829. doi: 10.1016/j.bbih.2024.100829. eCollection 2024 Oct.
Attention-Deficit Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder with complex genetic and environmental underpinnings. Emerging evidence suggests a significant role of gut microbiota in ADHD pathophysiology. This study investigates variations in gut microbiota composition and Short-Chain Fatty Acid (SCFA) profiles between children and adolescents with ADHD and healthy controls.
The study included 42 ADHD patients and 31 healthy controls, aged 6-18 years. Fecal samples were analyzed for microbial composition using 16S rRNA gene sequencing and for SCFA profiles through gas chromatography-mass spectrometry (GC-MS). The study assessed both α and β diversity of gut microbiota and quantified various SCFAs to compare between the groups.
ADHD subjects demonstrated significantly reduced gut microbiota diversity, as indicated by lower α-diversity indices (Shannon index, Observed species, Faith PD index) and a trend towards significance in β-diversity (Weighted UniFrac). Notably, the ADHD group exhibited significantly lower levels of key SCFAs, including acetic, propionic, isobutyric, isovaleric, and valeric acids, highlighting a distinct microbial and metabolic profile in these individuals.
This study uncovers significant alterations in gut microbiota and SCFA profiles in children with ADHD, compared to healthy controls. The observed changes in SCFAs, known for their associations with other behavioral and neurologic pathologies, and for their role in neural signaling. These findings offer a metabolite fingerprint that could potentially lead to novel diagnostic and treatment approaches for ADHD, emphasizing the importance of gut microbiota in the disorder's pathogenesis and management.
注意力缺陷多动障碍(ADHD)是一种常见的神经发育障碍,具有复杂的遗传和环境基础。新出现的证据表明肠道微生物群在ADHD病理生理学中起重要作用。本研究调查了ADHD儿童和青少年与健康对照组之间肠道微生物群组成和短链脂肪酸(SCFA)谱的差异。
该研究纳入了42名年龄在6至18岁之间的ADHD患者和31名健康对照。使用16S rRNA基因测序分析粪便样本的微生物组成,并通过气相色谱 - 质谱联用(GC - MS)分析SCFA谱。该研究评估了肠道微生物群的α和β多样性,并对各种SCFA进行定量以比较两组之间的差异。
ADHD受试者的肠道微生物群多样性显著降低,表现为较低的α多样性指数(香农指数、观察到的物种数、费思系统发育多样性指数),并且在β多样性(加权UniFrac)方面有显著趋势。值得注意的是,ADHD组的关键SCFA水平显著较低,包括乙酸、丙酸、异丁酸、异戊酸和戊酸,突出了这些个体独特的微生物和代谢特征。
本研究发现,与健康对照组相比,ADHD儿童的肠道微生物群和SCFA谱有显著改变。观察到的SCFA变化,已知它们与其他行为和神经病理学有关,并且在神经信号传导中起作用。这些发现提供了一种代谢物指纹图谱,可能会为ADHD带来新的诊断和治疗方法,强调了肠道微生物群在该疾病发病机制和管理中的重要性。